Analytical Data
-
基因名
ERV1
- Application
-
别名
(14 kDa regulatory protein)(Essential for respiration and vegetative growth protein 1)
-
种属
Saccharomyces cerevisiae
-
表达系统
Yeast
-
标签
C- His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P27882
-
表达区间
1-189aa
-
分子量
22.5 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
ERV1 (Endogenous Retrovirus 1) is a member of the class of endogenous retroviruses that are integrated into the genomes of many mammals, including humans. Research on ERV1 recombinant proteins has gained significance due to their potential roles in various biological processes and disease mechanisms. These proteins are believed to be involved in immune responses, with mechanisms that can modulate host cell activities. Furthermore, understanding ERV1 proteins can provide insights into the evolution of retroviruses and their interactions with host genomes. The study of ERV1 also extends to its implications in cancer biology, where its expression patterns may correlate with malignancies, suggesting a potential use as a biomarker or therapeutic target. Additionally, advances in recombinant DNA technology have enabled the production and characterization of ERV1 proteins, facilitating the exploration of their structure-function relationships. As a result, research on ERV1 recombinant proteins not only enhances our understanding of retroviral biology but also opens up avenues for innovative therapeutic strategies in treating diseases influenced by these viral components.
